chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 35-year-old female, who is 13 weeks pregnant with twins and allergic to penicillin, who on 03-MAY-2001 was vaccinated with a dose of varicella virus vaccine live and with a follow-up vaccination, "shortly after", with a dose of varicella virus vaccine live.  There was no concomitant medication.  Today, on 19-DEC-2005 the patient found out that the vaccine was not protecting her from the virus and that she was now susceptible to the virus.  It was reported that the patient had not recovered.  Unspecified medical attention was sought.  No product quality complaint was involved.  No other information was provided.  Additional information has been requested.
Shingles; Red spots like rashes on left cheek and on  butt; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Red spots like rashes on left cheek and on  butt) and HERPES ZOSTER (Shingles) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Shingles. Concomitant products included CYANOCOBALAMIN (VITAMIN B-12) and ESZOPICLONE (LUNESTA) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 25-Feb-2021, the patient experienced RASH (Red spots like rashes on left cheek and on  butt). On 02-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). At the time of the report, RASH (Red spots like rashes on left cheek and on  butt) and HERPES ZOSTER (Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment includes Acyclovir 400mg (but has not started taking it).
Narrative:  10/22/2020 COVID swab, result: NOT detected 11/18/2020 COVID swab, result: NOT detected COVID infection, following COVID vaccine series 01/06, MODERNA, dose #1 02/03, MODERNA, dose #2 03/15 COVID PCR result: not detected, FLU A PCR result: negative, FLU B PCR result: negative, RSV PCR result: negative 07/27 08/03 pt cc: cough, fever, myalgias, cough, dyspnea exposure: wife COVID+ 08/06 COVID swab, result: detected 08/12 SARS-COV-2 LINEAGE result: B.1.617.2 8/12 SARS-COV-2 CLADE results: 21A Delta
Date: 01/13/2010 10:48 AM  Pt. got the  H1N1 VACC.; though on December 10, 2009 she got the Pneumonia shot. She says she is still having pain where the shot was administered: "My L shoulder joint was hot @ the time of the shot. Experiencing pain to joint-collar bone and up into lower L side of skull. Pain is continual, weakness and loss of arm function for several days. She still cannot use arm much or sleep on her L side. Collar bone is still sensitive as is L base of skull. She is rubbing w/Flexall @ times, also taking Advil = pain is still there some what through the Advil."  ( Told Pt to wait in room while I would speak w/the midlevel that is working Today). Per  P.A.- Told Pt it is common for some people to have pain for one month or a little bit after a month. Pt was told to use warm compresses, ice, and to take Tylenol. Told Pt to call office if pain gets severe or won't go away. 06:39 PM: That same evening I called pt to offered an appt to be seeing though she wanted to keep the tips and if pain did not go away she will schedule an appt.
fever 105; evaluated by MD 28MAY93 general exam nl; dx vax induced febrile;
red blotches on his back and looked in mirror and saw it all on his legs and thighs and it was coming through skin.; feel something under skin; looked like red rash broke out on his thighs and seemed like the shingles; looked like red rash broke out on his thighs and seemed like the shingles; muscle spasms on the left side of his back; Stiffness and it was hard to straighten up, and it was catching in his left hip and lower part of his back and it was pretty severe; Stiffness and it was hard to straighten up, and it was catching in his left hip and lower part of his back and it was pretty severe; 2nd dose, 3 mg single; This is a spontaneous report from a contactable consumer (who is also the patient). A 77-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200), via an unspecified route of administration, administered in the left arm, on 01Mar2021 (also reported as 02Mar2021) a little before 10:00 close to an hour after arriving at 09:00, as 2nd dose, 3 mg single, for COVID-19 immunisation. The patient medical history was not reported. There were no concomitant medications. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9269), administered in the left arm shoulder, at 0.3 mg, for COVID-19 immunization. On 02Mar2021, the patient started having muscle spasms in the lower part of his back. The patient clarified that the muscle spasm was on the left side of his back which was the same side as the vaccination. On the same day, 02Mar2021, the patient experienced stiffness and it was hard to straighten up, it was catching in his left hip and lower part of his back and it was pretty severe. On 05Mar2021, the patient could feel something under his skin that looked like red rash broke out on his thighs and seemed like the shingles or something and he didn't know what that was. He stated that he saw red blotches on his back and looked in mirror and saw it all on his legs and thighs and it was coming through skin. The patient was recovering from muscle spasms, stiffness, and joint stiffness. The outcome of the remaining events was not recovered.
incorrect dose administered; pain; This spontaneous case was reported by a consumer and describes the occurrence of INCORRECT DOSE ADMINISTERED (incorrect dose administered) and PAIN (pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (incorrect dose administered) and PAIN (pain). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 UNK. At the time of the report, INCORRECT DOSE ADMINISTERED (incorrect dose administered) and PAIN (pain) outcome was unknown.            No concomitant medications were reported.
A Pfizer grey cap COVID-19 vaccine was given on 6/27/22, but this vial had previously been opened and punctured on 6/24/22. This puts the vaccine given on 6/27/22 past the 12 hour window that it can be used after puncturing.
Fatigue, malaise, migraines, and generalized papular rash involving chest, back, shoulders, and groin.
cold/flue-like symptoms; fever; the lymph nodes of the same arm of the injection are swollen/problems with his lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (cold/flue-like symptoms), VACCINATION SITE LYMPHADENOPATHY (the lymph nodes of the same arm of the injection are swollen/problems with his lymph nodes) and PYREXIA (fever) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced VACCINATION SITE LYMPHADENOPATHY (the lymph nodes of the same arm of the injection are swollen/problems with his lymph nodes). On 22-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INFLUENZA LIKE ILLNESS (cold/flue-like symptoms) and PYREXIA (fever). On 23-Apr-2021, INFLUENZA LIKE ILLNESS (cold/flue-like symptoms) and PYREXIA (fever) had resolved. At the time of the report, VACCINATION SITE LYMPHADENOPATHY (the lymph nodes of the same arm of the injection are swollen/problems with his lymph nodes) outcome was unknown.            No treatment medications are provided  No concomitant medications are provided.  Caller stated that he has wasted a lot of money on this and that it's consistently bothering him.
A wheal was not formed after pt was injected with 0.1 mL of the Jynneos/BN vaccine in the left forearm. There was no observed immediate reaction at the site and the pt did not complain of any discomfort. A wheal was formed 2 inches away from the site after a second attempt was made by another nurse.
Varicella vaccine stored in freezer at 28 deg x 24 deg. Recommended to revaccinated or draw titer.
This spontaneous report as received from a pharmacist refers to a 73 year old female patient with no drug reactions/allergies. In September 2013 the patient was vaccinated with a dose of 0.65 ml ZOSTAVAX, VIAL 19400 PFU, (lot #, expiration date unspecified) subcutaneous in the left arm. In 2013, a few days after receiving the ZOSTAVAX, she had pain in the left arm at the injection site. The patient reported to the pharmacist that the pain had stayed consistent since then, and had started to move up through her shoulder into her neck. Pharmacist stated that patient reported that she was seen by an unspecified nurse practitioner, but it was unclear whether she received any treatment. No Lab Diagnostics Studies Performed. The event outcome was reported as not recovered. Additional information has been requested.
Patient received vaccine. Parents stated and acknowledged patient was of age to receive Covid vaccine. Patient is actually 11 years old and not of age. Patient received vaccine. So far no adverse effect. I called parents to inform them patient was not of age to receive vaccine. Parents knew and were understanding. I let them know I would not be able to administer second dose.
wasn't feeling well; muscle soreness; Initial information received on 13-Nov-2019 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves Adult patient of unknown demographics who was not feeling well (PT: Malaise) and muscle soreness (Myalgia), while patient was vaccinated with INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot number not reported) for prophylaxis.  On an unknown date, (latency unknown) patient wasnot feeling well (PT: Malaise) and muscle soreness (Myalgia). Also reported that she had some side effects a few days after her dose.  Action taken, corrective treatment and event outcome was unknown at the time of reporting.
At 12pm 1/14/2010, child started having body aches, muscle aches stomache cramping, flushed but no fever, no rash, no redness to site but c/o "pin prick" feeling over body. MD was phoned and child was given Advil.
Received shot on 11/13/2007. By noon on 11-14, she experienced redness, swelling, hot to touch at site of injection, fever to 101 x3 days, and joint pain in hips, knees, back pain for several days. Her primary MD told her to take 800mg Ibuprofen Q6, as needed, Claritin, and Keflex (in case). She feels better today, 11-19.
Left leg felt heavy; left leg felt tingly; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had a history of allergy to levofloxacin (LEVAQUIN). The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Prior to vaccination, the patient had no symptoms associated for COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. On 18Mar2021, the patient experienced heaviness and tingling in the left leg that corresponded to the arm where the shot was received for 5 days after the vaccine. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of heaviness and tingling in the left leg were resolving.   No follow-up attempts are possible. No further information is expected.
Soreness and pain at the injection site advanced to swelling and a knot on right arm.  Knot developed to a quarter in size with in 24 hours.  Pain when lifting right arm.  No treatment required.
This spontaneous report as received from a registered nurse refers to an unspecified number of patient of unknown age and gender. No information about the patients medical history and concurrent conditions were reported. On an unknown date, the patients were vaccinated with an improperly stored dose of PROQUAD (lot# L046509, expiration date: 17-MAY-2017) (dose and route of administration were not reported) for prophylaxis. Concomitant therapy was not reported. There was no adverse event reported. Follow-up information has been received on 29-NOV-2016, indicating that all telephone attempts to obtain follow-up information have been unsuccessful. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1610USA002775: MERCK 1610USA006328: Mfr number.
No reaction for 20 hours - then rash, welts. Head foggy, lip and tongue numb. 2 weeks - joints ache, still head foggy. The Pharmacist said I would have a reaction within the first few minutes if I were going to have one but I had no reaction till about 20 hours after. A rash on my stomach, breasts, back with welting, the injection site was about a 50cent piece size red and swollen. The rash was sensitive but not painful. I felt hot and fatigued. I felt terrible and thought I had gotten shingles, my head was foggy and still is some, my joints now hurt and I do not feel well as I had before the vaccine. I regret getting the vaccine. I hope you include these symptoms as a warning to others.
I received the shot and about one minute later I felt a little dizzy and light head.  They sat me down and about couple minutes later I felt my heart rate racing and felt flushed.  I reported how I felt the the staff and they put me in a recliner.  The rapid heart rate went away about a minute later.  I stayed at the vaccine clinic for total of 35 minutes after the shot.  They made sure I felt o.k. before I left.  I didn't have that feeling again.  I felt fine the rest of the day and today.  I have had that same feeling before not from vaccine.  I have never had reaction to vaccine or medications.   2 years ago I thought I was allergic to avocado or avocado oil because I had a couple of incidence of having that same dizzy fast heart rate feeling after avocado oil.  I went to an allergist and got tested and was negative for avocado and he also tested me for shell fish because I have had history of being itchy after eating shellfish.  I was negative for both.  I haven't had that same reaction for several years since that incident.  I have been able to eat avocado and shellfish without problem.  I don't really know if this is an allergic reaction or an immune response to the vaccine.  I am going to see my allergist on 1/6/21 see what he thinks.  I am wondering if I should get the second dose.
Indention noted in lt upper arm, left upper arm atrophy, tenderness at site.
Swelling, erythema, itching.  Patient seen at PCP office and treated with Medrol Dose Pak.
Began approx 15 months fever; loss of eye contact; loss of language/communication; began hand flapping, stimming began; increased irritability diagnosed with Autism Disorder.
15 minutes after the injection my wife had slightly numb fingers on her left hand.  10 to 15 minutes later, her heart was racing and she nearly passed out several times over the next 30 minutes.  Her left fingers and tongue went numb.  Her speech was impacted.  She had a very hard time to find the words to speak - similar to a stroke.  She had delayed and choppy speech and complained about not being able to think of the words to say.  She had some stuttering as well.  We went to the ER, following the advice from the advice nurse.  The ER was very full.  After waiting roughly 3 hours in the ER, her speech had come back and was fairly normal.  Her numbness was almost all gone as well.  We never got to see a physician.  Today, 05/04/5021, her symptoms are sore arm, slight fever, and lethargy.
Rash to upper trunk with few spots red in color 11/6-8/ Worsened redness to body. No wheezing water eyes. SOB. Patient sent to ER received Benadryl prior to ER visit. ER admin : Solution Medrol 40mg/IM Benadryl 12.5 mg/IM, Zantac 150 mg po.
death I63.9 - CVA (cerebral vascular accident) (CMS/HCC)
had a muscle pain in legs; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (had a muscle pain in legs) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Blood pressure high and Back disorder NOS (back problem). Concomitant products included HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN HCTZ) for Blood pressure high, TRAMADOL for Pain, VITAMINS NOS, OMEPRAZOLE and MONTELUKAST for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced MYALGIA (had a muscle pain in legs). At the time of the report, MYALGIA (had a muscle pain in legs) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was also taking concomitant drug Mesaconic acid (2 tablets a day) for an unknown indication. It was reported that no treatment was taken for the events.
Patient received vaccine at 1410 and was told to wait 30 minutes with EMT. At 1420, patient reported feeling "tightness" in throat and chest. Patient was given 25mg PO of Benadryl at 1421. Patient's vitals were "within normal limits" per EMT  at 1440. Patient was assessed by lead RN  at 1450 and found to have a BP of 160/90, pulse of 66 BPM, 16 RPM, and A&Ox3. At 1500, the patient's blood pressure was reassessed by lead RN and found to be 156/88. Patient reports "feeling better" and requested to go home.
Had a rash over my stomach within 30 minutes.  but felt fine that afternoon.  Rash reappeared by evening and by midnight I had chills fever and all the symptoms described.  Main concern was the immediate rash.
DEATH; This spontaneous report received from a consumer via social media concerned a female of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number and expiry date were not reported) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient died from unknown cause of death. It was unspecified if an autopsy was performed. It was reported as "Your vaccine killed my mother". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20230764359- Death. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Patient arrived stating for his first COVID-19 vaccination dose. Patient assessed as per protocol. Vaccine dose administered. When attempting to acknowledge administration of vaccination, pop-up message appeared stating "patient has completed the series. Additional doses should not be given". Further investigation revealed patient has received previous vaccine doses 2/27/21 and 3/27/21. Incident reported to vaccine center supervisor.
Patient had a flue shot at 9:00 A.M.sunday 10/28/07.   At 4:00 P.M.had strong shiver/chills fell like vomiting; she asked for cold water;at 6:00 P.M. had 100.4 fever. Given her one ALEVE pill; at7:30P.M.fever down to100.0. at 9:00P.M.fever down to 99.4   She never had a influenza vaccine before.
This spontaneous report as received from a registered nurse refers to a patient of unknown demographics. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported. On 31-JUL-2018, the patient was vaccinated with improperly stored doses of PROQUAD either from lot # R002939, expiry date: 29-JUL-2019 or lot # R006218, expiry date: 28-AUG-2019 (dose, frequency and route were not reported) for prophylaxis. Diluent MRK Inj was properly stored. No adverse effects were reported. No product quality complaint was involved. The PROQUAD was stored in temperature of 15 degree Fahrenheit (F) to 46 F for 14 hours on 16-JUN-2018. No previous temperature excursion was reported. A digital data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1808USA001261; US-009507513-1808USA004381; US-009507513-1808USA004382; US-009507513-1808USA004383; US-009507513-1808USA004384; US-009507513-1808USA004385; US-009507513-1808USA004380; US-009507513-1808USA004379; US-009507513-1808USA004376; US-009507513-1808USA004377l; US-009507513-1808USA004378; US-009507513-1808USA004386; US-009507513-1808USA004387; US-009507513-1808USA004388; US-009507513-1808USA004362; US-009507513-1808USA004363; US-009507513-1808USA004389; US-009507513-1808USA004390; US-009507513-1808USA004391; US-009507513-1808USA004364; US-009507513-1808USA004392; US-009507513-1808USA004393; US-009507513-1808USA004394; US-009507513-1808USA004395; US-009507513-1808USA004396; US-009507513-1808USA004365; US-009507513-1808USA004366; US-009507513-1808USA004367; US-009507513-1808USA004397; US-009507513-1808USA004399; US-009507513-1808USA004368; US-009507513-1808USA004369; US-009507513-1808USA004400; US-009507513-1808USA004401; US-009507513-1808USA004370; US-009507513-1808USA004371; US-009507513-1808USA004372; US-009507513-1808USA004373; US-009507513-1808USA004374; US-009507513-1808USA004375.
This spontaneous report as received from a health professional refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 19-NOV-2015, the patient was vaccinated with improperly stored (exposed to the following temperatures and cumulative time frames colder than 36 F: In September 2015, the coldest temperature was 34 F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34 F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34 F for 192 hours, for a total of 1,031.3 hours (43 days)) VAQTA injection, 0.5 ml (lot # L018499, exp. date: 25-FEB-2017) (route and strength unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Redness and swelling, pain L lateral thigh today. Dr. dx as inflammatory reaction.
Patient states that she got the vaccine and 3 hours later was at the mall at the food court when she was eating. Patient suddenly had the feeling of her throat closing up. Patient stopped eating and had a bout of emesis. Symptoms resolved shortly after. Patient did not attempt to finish eating.